Evidence map›Paper›PMID 32429301›Full record

ArticleInternational journal of molecular sciences2020

Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition.

Carolina Pellegrini, Simona Daniele, Luca Antonioli, Laura Benvenuti, Vanessa D'Antongiovanni, Rebecca Piccarducci, Deborah Pietrobono, Valentina Citi, Eugenia Piragine, Lorenzo Flori and 12 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Carolina PellegriniDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Simona DanieleDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Luca AntonioliUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Laura BenvenutiUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Vanessa D'AntongiovanniUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Rebecca PiccarducciDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Deborah PietrobonoDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Valentina CitiDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Eugenia PiragineDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Lorenzo FloriDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Chiara IppolitoUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Cristina SegnaniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Pablo Palazon-RiquelmeManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester M13 9PL, UK.
Gloria Lopez-CastejonManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester M13 9PL, UK.
Alma MartelliDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Rocchina ColucciDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
Nunzia BernardiniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Maria Letizia TrincavelliDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Vincenzo CalderoneDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Claudia MartiniDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Corrado BlandizziUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Matteo FornaiUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
University of Pisa · ITUniversity of Manchester · GBUniversity of Padua · IT

Funding

Università di Pisa PRA_2018_31
6 · The paper itself

Abstract

Increasing evidence suggests that intestinal dysfunctions may represent early events in Alzheimer's disease and contribute to brain pathology. This study examined the relationship between onset of cognitive impairment and colonic dysfunctions in a spontaneous AD model before the full development of brain pathology. SAMP8 mice underwent Morris water maze and assessment of faecal output at four, six and eight months of age. In vitro colonic motility was examined. Faecal and colonic Aβ, tau proteins, α-synuclein and IL-1β were assessed by ELISA. Colonic citrate synthase activity was assessed by spectrophotometry. Colonic NLRP3, caspase-1 and ASC expression were evaluated by Western blotting. Colonic eosinophil density and claudin-1 expression were evaluated by immunohistochemistry. The effect of Aβ on NLRP3 signalling and mitochondrial function was tested in cultured cells. Cognitive impairment and decreased faecal output occurred in SAMP8 mice from six months. When compared with SAMR1, SAMP8 animals displayed: (1) impaired in vitro colonic contractions; (2) increased enteric AD-related proteins, IL-1β, active-caspase-1 expression and eosinophil density; and (3) decreased citrate synthase activity and claudin-1 expression. In THP-1 cells, Aβ promoted IL-1β release, which was abrogated upon incubation with caspase-1 inhibitor or in ASC

Indexed as

Gastrointestinal MotilityProdromal Symptomsalpha-SynucleinAlzheimer DiseaseAmyloid beta-PeptidesAnimalsCARD Signaling Adaptor ProteinsCaspase 1Claudin-1CognitionColonEosinophilsFecesFeeding BehaviorHumansInflammasomesalpha-SynucleinAmyloid beta-PeptidesCARD Signaling Adaptor ProteinsCaspase 1Claudin-1InflammasomesInterleukin-1betaNerve Tissue ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinProtein AggregatesPycard protein, mousetau ProteinsAlzheimer’s diseasecolonic motilityenteric inflammationenteric neuronal codinginterleukin-1βmild cognitive impairmentmitochondrial functionNLRP3 inflammasometau proteinα-synucleinβ-amyloid protein

Identifiers

PMID32429301
PMCPMC7278916
OpenAlexW3024429795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.